Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Operating Cash Flow Growth

-5.58%

TTM · Period ending:

LCTX logo

LCTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-5.58%
LCTX TTM Cash from Operations YoY % (-40.00% → -5.58%)
High-resolution chart · PNG

LCTX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-5.5767%
0.3785%
18.0712%
10.4459%
-2.4665%
3.9469%
19.1626%
26.2075%
29.6488%
27.9864%
-2,797.4504%
-984.2075%
-859.3545%
-656.3898%
104.4947%
114.9556%
117.6655%
126.0349%
-19.2781%
-18.8133%
-4.9346%
19.914%
38.1695%
39.0898%
30.7984%
7.3649%
-3.4486%
-4.8496%
-3.3158%
8.85%
-1.1961%
8.7523%
10.9769%
9.288%
27.9001%
28.9471%
30.2375%
27.4707%
4.9793%
-19.4267%
-36.2184%
-32.5361%
-14.644%
-3.4825%
-1.593%
-14.3756%
-31.6707%
-48.2777%
-47.8484%
-56.5182%
-49.9458%
-41.5705%
-45.0879%
-33.6287%
-44.7671%
-43.0801%
-50.8706%
-55.2681%
-75.7936%
-120.2143%
-112.5144%
-126.7282%
-81.5257%
-47.7655%
-88.7257%
-89.0317%
-165.5416%
-171.3118%
-117.5068%
-109.1502%
-29.3767%
-34.5738%
-10.4949%
-25.4439%
1.7619%
-48.6184%
-1.1655%
40.0347%
10.7435%
63.1063%
22.6764%
-5.1574%
7.9748%
-8.7714%
-36.0745%
-65.3581%
-134.9171%
-156.6157%
35.8577%
57.3991%
69.2768%
63.0288%
33.1687%
29.2838%
33.6678%
49.7824%
33.8027%
32.9596%
33.9136%
28.5101%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.